Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol. 2011 Apr; 13(4):384-92.